Author

J.-M. Diez

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 4

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Research Focus:host-pathogen & immune response· 4 Organism:human· 2 Assay:proteomics· 1

Frequent Co-Authors

C. Romero· 4 shared R. Gajardo· 4 shared B. Clotet· 1 shared B. Trinite· 1 shared D. Casals· 1 shared E. Pradenas· 1 shared J. Blanco· 1 shared M. Cruz· 1 shared

Activity by Year

2020-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 38 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersImmunology

C. Romero

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Seasonal IVIG contains high infectivity neutralizing and hemagglutination inhibition activity against seasonal flu virus strains selected for vaccines (2020-22)

J.-M. Diez, D. Casals, C. Romero, R. Gajardo

The paper tests IVIG for neutralizing and hemagglutination inhibition against seasonal flu strains and finds potent activity, suggesting potential as an adjunct therapy for influenza.

bioRxiv · Jan 31, 2022 · PreprintImmunology

Anti-SARS-CoV-2 hyperimmune immunoglobulin provides potent and robust neutralization capacity and antibody-dependent cellular cytotoxicity and phagocytosis induction through N and S proteins

J.-M. Diez, C. Romero, M. Cruz, P. Vandeberg, W. K. Merritt, E. Pradenas, B. Trinite, J. Blanco, B. Clotet, T. Willis, R. Gajardo

This study evaluates the neutralization and antibody-dependent cellular effects of anti-SARS-CoV-2 hyperimmune immunoglobulin against multiple SARS-CoV-2 isolates and variants.

The Journal of Infectious Diseases · Oct 25, 2021Peer-reviewedImmunology

Effective presence of antibodies against common human coronavirus in IgG immunoglobulin medicinal products.

J.-M. Diez, C. Romero, R. Gajardo

The paper tests IgG immunoglobulin products from different geographic regions for antibodies against common human coronaviruses and finds similar anti-HCoV activity across products, with highest activity against HCoV-229E.

bioRxiv · Jul 23, 2021Immunology

Currently available intravenous immunoglobulin (Gamunex(C)-C and Flebogamma(C) DIF) contains antibodies reacting against SARS-CoV-2 antigens

J.-M. Diez, C. Romero, R. Gajardo

This study assesses IVIG products for antibodies against SARS-CoV-2 antigens, finding cross-reactivity with related coronaviruses.

bioRxiv · Apr 7, 2020Immunology